Literature DB >> 10365398

Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.

D J Austin1, R M Anderson.   

Abstract

The emergence of antibiotic resistance in a wide variety of important pathogens of humans presents a worldwide threat to public health. This paper describes recent work on the use of mathematical models of the emergence and spread of resistance bacteria, on scales ranging from within the patient, in hospitals and within communities of people. Model development starts within the treated patient, and pharmacokinetic and pharmacodynamic principles are melded within a framework that mirrors the interaction between bacterial population growth, drug treatment and the immunological responses targeted at the pathogen. The model helps identify areas in which more precise information is needed, particularly in the context of how drugs influence pathogen birth and death rates (pharmacodynamics). The next area addressed is the spread of multiply drug-resistant bacteria in hospital settings. Models of the transmission dynamics of the pathogen provide a framework for assessing the relative merits of different forms of intervention, and provide criteria for control or eradication. The model is applied to the spread of vancomycin-resistant enterococci in an intensive care setting. This model framework is generalized to consider the spread of resistant organisms between hospitals. The model framework allows for heterogeneity in hospital size and highlights the importance of large hospitals in the maintenance of resistant organisms within a defined country. The spread of methicillin resistant Staphylococcus aureus (MRSA) in England and Wales provides a template for model construction and analysis. The final section addresses the emergence and spread of resistant organisms in communities of people and the dependence on the intensity of selection as measured by the volume or rate of drug use. Model output is fitted to data for Finland and Iceland and conclusions drawn concerning the key factors determining the rate of spread and decay once drug pressure is relaxed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365398      PMCID: PMC1692559          DOI: 10.1098/rstb.1999.0425

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  44 in total

1.  Infection control programmes--are they cost-effective?

Authors:  S Mehtar
Journal:  J Hosp Infect       Date:  1995-06       Impact factor: 3.926

2.  Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness.

Authors:  R E Lenski; S C Simpson; T T Nguyen
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

3.  Modeling and simulating the evolution of resistance against antibiotics.

Authors:  E Massad; S Lundberg; H M Yang
Journal:  Int J Biomed Comput       Date:  1993-07

Review 4.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 5.  Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.

Authors:  D K Shay; D A Goldmann; W R Jarvis
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

6.  Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.

Authors:  G L Drusano; D E Johnson; M Rosen; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

7.  Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.

Authors:  J G Morris; D K Shay; J N Hebden; R J McCarter; B E Perdue; W Jarvis; J A Johnson; T C Dowling; L B Polish; R S Schwalbe
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

8.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

9.  Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.

Authors:  J R Aeschlimann; M J Zervos; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  52 in total

1.  Adherence and drug resistance: predictions for therapy outcome.

Authors:  L M Wahl; M A Nowak
Journal:  Proc Biol Sci       Date:  2000-04-22       Impact factor: 5.349

2.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

Review 3.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

4.  Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway.

Authors:  Maren K R Sogstad; E Arne Høiby; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  J V Robotham; D R Jenkins; G F Medley
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

6.  Stochastic model of an influenza epidemic with drug resistance.

Authors:  Yaji Xu; Linda J S Allen; Alan S Perelson
Journal:  J Theor Biol       Date:  2007-05-17       Impact factor: 2.691

Review 7.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

8.  Modeling the mechanism of postantibiotic effect and determining implications for dosing regimens.

Authors:  Patricia Geli
Journal:  J Math Biol       Date:  2009-02-03       Impact factor: 2.259

9.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

Review 10.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.